KR101782451B1 - 인간 엔테로바이러스에 대한 백신 - Google Patents

인간 엔테로바이러스에 대한 백신 Download PDF

Info

Publication number
KR101782451B1
KR101782451B1 KR1020147015175A KR20147015175A KR101782451B1 KR 101782451 B1 KR101782451 B1 KR 101782451B1 KR 1020147015175 A KR1020147015175 A KR 1020147015175A KR 20147015175 A KR20147015175 A KR 20147015175A KR 101782451 B1 KR101782451 B1 KR 101782451B1
Authority
KR
South Korea
Prior art keywords
delete delete
enterovirus
human enterovirus
protein
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147015175A
Other languages
English (en)
Korean (ko)
Other versions
KR20140096343A (ko
Inventor
매리 제인 카르도사
모하마드 파크루딘 자미루딘
샤리파 빈티 하미드
Original Assignee
센티넥스트 테라퓨틱스 에쓰디엔 비에이취디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 센티넥스트 테라퓨틱스 에쓰디엔 비에이취디 filed Critical 센티넥스트 테라퓨틱스 에쓰디엔 비에이취디
Publication of KR20140096343A publication Critical patent/KR20140096343A/ko
Application granted granted Critical
Publication of KR101782451B1 publication Critical patent/KR101782451B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32323—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32371—Demonstrated in vivo effect
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020147015175A 2011-11-03 2012-11-01 인간 엔테로바이러스에 대한 백신 Expired - Fee Related KR101782451B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MYPI2011005318 2011-11-03
MYPI2011005318 2011-11-03
PCT/IB2012/003114 WO2013098655A2 (en) 2011-11-03 2012-11-01 Antigens and vaccines directed against human enteroviruses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020177026513A Division KR101900460B1 (ko) 2011-11-03 2012-11-01 인간 엔테로바이러스에 대한 백신

Publications (2)

Publication Number Publication Date
KR20140096343A KR20140096343A (ko) 2014-08-05
KR101782451B1 true KR101782451B1 (ko) 2017-09-29

Family

ID=47215776

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020147015175A Expired - Fee Related KR101782451B1 (ko) 2011-11-03 2012-11-01 인간 엔테로바이러스에 대한 백신
KR1020177026513A Expired - Fee Related KR101900460B1 (ko) 2011-11-03 2012-11-01 인간 엔테로바이러스에 대한 백신
KR1020187026574A Expired - Fee Related KR102002103B1 (ko) 2011-11-03 2012-11-01 인간 엔테로바이러스에 대한 백신

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020177026513A Expired - Fee Related KR101900460B1 (ko) 2011-11-03 2012-11-01 인간 엔테로바이러스에 대한 백신
KR1020187026574A Expired - Fee Related KR102002103B1 (ko) 2011-11-03 2012-11-01 인간 엔테로바이러스에 대한 백신

Country Status (16)

Country Link
US (3) US9987350B2 (enExample)
EP (2) EP3290050B1 (enExample)
JP (2) JP6190378B2 (enExample)
KR (3) KR101782451B1 (enExample)
CN (2) CN107441484A (enExample)
AU (1) AU2012360168C1 (enExample)
BR (1) BR112014010658A2 (enExample)
CA (1) CA2854594C (enExample)
CL (1) CL2014001160A1 (enExample)
HK (2) HK1245128A1 (enExample)
MX (2) MX363409B (enExample)
MY (1) MY172501A (enExample)
PH (2) PH12014501041B1 (enExample)
SG (1) SG11201401998VA (enExample)
TW (2) TWI571512B (enExample)
WO (1) WO2013098655A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI700295B (zh) * 2013-12-16 2020-08-01 馬來西亞商Ｍａｂ探索私人有限公司 對會感染人類之腸病毒具有專一性之抗體
HRP20220070T1 (hr) 2014-04-23 2022-04-01 Modernatx, Inc. Cjepiva nukleinske kiseline
KR20170068410A (ko) * 2014-04-29 2017-06-19 내셔날 헬스 리서치 인스티튜트 엔테로바이러스 감염증에 대항하는 아데노바이러스 벡터-기반 백신
CN111925423B (zh) * 2014-11-07 2022-08-19 普莱柯生物工程股份有限公司 一种抗o型口蹄疫的疫苗组合物及其制备方法和应用
CN106554965B (zh) * 2015-09-28 2019-08-27 斯澳生物科技（苏州）有限公司 用于制备ev71病毒样颗粒的核酸构建体和方法
CN105348391B (zh) * 2015-11-03 2019-06-28 李越希 埃可病毒6型vp1蛋白特异性抗原表位及其融合蛋白的制备、应用
CN105802923B (zh) * 2016-04-14 2019-07-16 中国科学院生物物理研究所 一种重组脊髓灰质炎病毒样颗粒及其制备方法与应用
SG11201809048PA (en) 2016-04-22 2018-11-29 Integrated Research Associates Llc Improved method for producing virus like particles
US20190247488A1 (en) 2016-10-07 2019-08-15 Sentinext Therapeutics Sdn Bhd Expression cassettes and methods for obtaining enterovirus virus-like particles
US20190224304A1 (en) * 2016-10-07 2019-07-25 Sentinext Therapeutics Sdn Bhd Chimeric enterovirus virus-like particles
KR102091372B1 (ko) 2017-02-28 2020-05-27 대한민국 엔테로바이러스 71형 불활화 백신 및 이의 용도
CN108624601B (zh) * 2017-03-17 2023-08-11 中国科学院上海巴斯德研究所 酵母表达的柯萨奇病毒a10病毒样颗粒及其应用
CN111050795B (zh) * 2017-07-03 2023-09-22 巴拉特生物技术国际有限公司 基于合成的多肽表位的疫苗组合物
CN108152511B (zh) * 2017-12-20 2019-01-04 广州瑞辉生物科技股份有限公司 柯萨奇A16病毒抗原多肽及其IgM抗体检测试剂盒
CN108424881B (zh) * 2018-03-23 2021-07-27 中国食品药品检定研究院 一株肠道病毒68型及其在制备ev-d68型感染动物中的应用
JPWO2020067027A1 (ja) * 2018-09-28 2021-08-30 一般財団法人阪大微生物病研究会 Ｖｌｐ発現ｃｈｏ細胞株の構築
CN110045105B (zh) * 2018-11-09 2022-04-26 广州市妇女儿童医疗中心 柯萨奇A16病毒IgA抗体量子点免疫荧光层析试纸条及试剂盒
EP4582440A3 (en) * 2018-12-21 2025-10-08 The Regents of the University of California Il-10-containing vaccines and uses thereof
CN110684781B (zh) * 2019-06-24 2021-05-28 四川农业大学 一种3型鸭甲肝病毒突变基因isa-a117c-t1142a及构建方法
CN112048004B (zh) * 2020-07-14 2021-10-22 桂林医学院 一种柯萨奇病毒b5型病毒样颗粒、其制备方法及应用
WO2022070210A1 (en) * 2020-09-29 2022-04-07 Bharat Biotech International Limited Stable formulations of low abundance enteroviruses vaccines and process of manufacture thereof
CN114107392A (zh) * 2021-11-22 2022-03-01 昆明理工大学 一种cvb5病毒类病毒样颗粒的制备方法
CN115010813B (zh) * 2022-05-19 2024-04-05 桂林医学院 一种肠道病毒71型病毒样颗粒、其制备方法及应用
CN116200348A (zh) * 2022-09-21 2023-06-02 武汉生物制品研究所有限责任公司 一种适应Vero细胞的柯萨奇病毒A10型毒株的构建方法及其应用
US11826418B1 (en) 2023-01-06 2023-11-28 King Faisal University Virus-like particle (VLP)-based vaccine against CVB4
WO2025029700A1 (en) * 2023-07-28 2025-02-06 Modernatx, Inc. Vlp enteroviral vaccines
CN117456519B (zh) * 2023-12-22 2024-03-12 江西科益高新技术有限公司 一种用于工控安全的仿真光电靶标装置及其仿真方法
CN120665160B (zh) * 2025-08-21 2026-03-20 国药中生生物技术研究院有限公司 肠道病毒71型的突变体及其病毒样颗粒

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508708A (en) 1981-06-05 1985-04-02 De Staat Der Nederlanden, Vertegenwoozdigd Doozde Minister Van Volksgezondheid En Milieuhygiene Virus vaccines and process for preparing the same
US20060182762A1 (en) * 2003-05-21 2006-08-17 Amsterdam Institute Of Viral Genomics B.V. Enterovirus, vaccines, medicaments and diagnostic kits

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360417A1 (en) * 2001-11-26 2003-06-10 Duke University Genetically stable expression vector
US20050112095A1 (en) * 2002-07-09 2005-05-26 Tsu-An Hsu Internal ribosome entry sites for recombinant protein expression
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
ATE494906T1 (de) * 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
EP2035565A4 (en) * 2006-06-30 2010-07-21 Novavax Inc METHODS OF ENHANCING THE INCORPORATION OF PROTEINS IN VIRUS-LIKE PARTICLES (VLPs)
US9758779B2 (en) * 2008-08-28 2017-09-12 Novartis Ag Cell surface display of polypeptide isoforms by stop codon readthrough
US8663951B2 (en) * 2009-01-09 2014-03-04 Academia Sinica Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system
CN101831410B (zh) 2009-03-09 2013-04-17 北京工业大学 重组肠病毒71型病毒样颗粒的制备方法
GB0918375D0 (en) * 2009-10-20 2009-12-02 Animal Health Inst Construct
TWI670373B (zh) * 2011-02-08 2019-09-01 淡馬錫生命科學實驗室有限公司 用於有效率地表面呈示抗原蛋白質之新穎表現匣

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508708A (en) 1981-06-05 1985-04-02 De Staat Der Nederlanden, Vertegenwoozdigd Doozde Minister Van Volksgezondheid En Milieuhygiene Virus vaccines and process for preparing the same
US20060182762A1 (en) * 2003-05-21 2006-08-17 Amsterdam Institute Of Viral Genomics B.V. Enterovirus, vaccines, medicaments and diagnostic kits

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
International Journal of Infectious Diseases. Vol. 12, No. Suppl.1, p. E254 (2008)
Vaccine. Vol. 26, pp. 1855-1862 (2008)*
Vaccine. Vol. 28, No. 43, pp. 6951-6957 (2010)

Also Published As

Publication number Publication date
JP2014532691A (ja) 2014-12-08
PH12014501041A1 (en) 2014-08-04
BR112014010658A2 (pt) 2017-06-13
EP3290050A1 (en) 2018-03-07
CL2014001160A1 (es) 2014-11-03
EP2773372A2 (en) 2014-09-10
PH12019500289A1 (en) 2020-02-17
KR20140096343A (ko) 2014-08-05
EP2773372B1 (en) 2018-12-26
CN104093420B (zh) 2017-07-28
TW201716576A (zh) 2017-05-16
MX363409B (es) 2019-03-20
WO2013098655A9 (en) 2013-12-19
US20150140027A1 (en) 2015-05-21
PH12014501041B1 (en) 2014-08-04
AU2012360168A2 (en) 2015-04-30
WO2013098655A3 (en) 2013-09-12
MX2018013782A (es) 2021-12-08
CA2854594C (en) 2018-08-21
MX2014005315A (es) 2015-03-09
KR20180104201A (ko) 2018-09-19
TWI571512B (zh) 2017-02-21
US10555997B2 (en) 2020-02-11
TW201333195A (zh) 2013-08-16
JP6190378B2 (ja) 2017-08-30
TWI626308B (zh) 2018-06-11
WO2013098655A2 (en) 2013-07-04
US20180271971A1 (en) 2018-09-27
CN104093420A (zh) 2014-10-08
KR102002103B1 (ko) 2019-07-19
AU2012360168C1 (en) 2017-09-28
KR101900460B1 (ko) 2018-11-08
US10548964B2 (en) 2020-02-04
JP6419271B2 (ja) 2018-11-07
HK1202803A1 (en) 2015-10-09
CN107441484A (zh) 2017-12-08
HK1251492B (en) 2019-10-25
EP3290050B1 (en) 2019-01-02
AU2012360168A1 (en) 2014-05-22
CA2854594A1 (en) 2013-07-04
KR20170109700A (ko) 2017-09-29
AU2012360168B2 (en) 2017-06-22
US9987350B2 (en) 2018-06-05
SG11201401998VA (en) 2014-05-29
MY172501A (en) 2019-11-27
HK1245128A1 (zh) 2018-08-24
US20180243400A1 (en) 2018-08-30
JP2017226677A (ja) 2017-12-28

Similar Documents

Publication Publication Date Title
KR102002103B1 (ko) 인간 엔테로바이러스에 대한 백신
HK1251492A1 (en) Vaccines directed against human enteroviruses
US20150056244A1 (en) Antigens and Vaccines Directed Against Human Enteroviruses
CN113637693B (zh) 用于疫苗中的登革热病毒嵌合式构建物的组合物及方法
US20050053624A1 (en) West nile virus vaccine
CN111961654B (zh) 耐热表型稳定遗传、携带负标记的重组口蹄疫病毒无毒株及o/a型口蹄疫二价灭活疫苗
WO2018066999A2 (en) Chimeric enterovirus virus-like particles
BR122020022788B1 (pt) Polipeptídeo quimérico, composição imunogênica e uso de um polipeptídeo quimérico
HK1202803B (en) Antigens and vaccines directed against human enteroviruses
TW201825676A (zh) 嵌合型腸病毒病毒樣顆粒
TW201825675A (zh) 用於獲得腸病毒病毒樣顆粒之表現匣及方法

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20200922

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20200922